Oruka Therapeutics (ORKA) Misses Q3 EPS by 55c
Tweet
Share
E-mailGet Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics (NASDAQ: ORKA) reported Q3 EPS of ($0.55).
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vipshop Holdings (VIPS) Misses Q2 EPS by 103c; misses on guidance
- Netflix (NFLX) PT Raised to $95 at Wolfe Research
- Raymond James Upgrades AMD (AMD) to Strong Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
